Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001750019-19-000009
Filing Date
2019-03-29
Accepted
2019-03-29 17:10:24
Documents
20
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tcrr10k12312018.htm 10-K 2224504
2 EXHIBIT 23.1 KPMG CONSENT a231consentofindependentre.htm EX-23.1 4308
3 EXHIBIT 31.1 a311certificationofprincip.htm EX-31.1 7624
4 EXHIBIT 31.2 a312certificationofprincip.htm EX-31.2 7680
5 EXHIBIT 32.1 a321certifcationsofprincip.htm EX-32.1 5432
6 tc110cytokinesa01.jpg GRAPHIC 50930
7 tcr2logo.jpg GRAPHIC 184107
8 tcrr10kb7.jpg GRAPHIC 294611
9 tcrr10kb8.jpg GRAPHIC 127414
10 tcrr10kb10.jpg GRAPHIC 154917
11 tcrr10kb11.jpg GRAPHIC 112721
12 tcrr10kb13.jpg GRAPHIC 269888
13 tcrr10kb14.jpg GRAPHIC 91187
14 tcrr10kb15-1.jpg GRAPHIC 68390
15 tcrr10kb15-2.jpg GRAPHIC 79027
16 tcrr10kb16.jpg GRAPHIC 89884
17 tcrr10kb17.jpg GRAPHIC 90686
18 tcrr10kb19.jpg GRAPHIC 93009
19 tcrr10kb20-1.jpg GRAPHIC 68291
20 tcrr10kb22.jpg GRAPHIC 194717
  Complete submission text file 0001750019-19-000009.txt   4954287
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

EIN.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38811 | Film No.: 19717570
SIC: 2836 Biological Products, (No Diagnostic Substances)